Szpital Kliniczny Im. Dr. Józefa Babińskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej W Krakowie
Kraków-Podgórze, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 12 652 45 70
- Websitehttps://babinski.pl/
About this provider
This is the Mental Health Clinic (Poradnia Zdrowia Psychicznego) contact point of Szpital Kliniczny im. dr. Józefa Babińskiego, Kraków's specialist psychiatric clinical hospital at ul. Babińskiego 29 in the Podgórze district. Per NFZ data it provides program B.147 — fully funded esketamine (Spravato) for treatment-resistant depression — with no queue reported as of June 2026. The clinic route suits the program's outpatient design: supervised nasal spray sessions without hospitalization. The hospital publishes the program description on its website and also runs inpatient psychiatric wards.
Services & programs
- Mental Health Clinic (Poradnia Zdrowia Psychicznego) — program contact point, registration +48 12 652 45 70
- Inpatient psychiatric wards on the same campus (ul. Babińskiego 29)
- Psychological outpatient clinic for children and adolescents (Kraków-Podgórze)
- NFZ drug program B.147 — esketamine for treatment-resistant depression (program description published by the hospital)
Common questions
How is this entry different from the hospital's other program listing?
The Babiński Hospital has two NFZ contact points for program B.147 at the same address: the Psychiatric Ward (registration +48 12 652 43 21) and this Mental Health Clinic (registration +48 12 652 45 70). Either can be your entry route.
Do I need to be hospitalized for esketamine treatment?
No — the program is designed for outpatient administration: you self-administer the nasal spray under staff supervision during scheduled visits and remain under observation afterwards, while taking a prescribed oral antidepressant at home.
Who can join and for how long?
Adults aged 18-75 with moderate-to-severe depression that failed at least two antidepressants, qualified by the center's psychiatrists; treatment is fully NFZ-funded and lasts up to 34 weeks.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified